BioSpace News Archive

BioCapital

Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring System

Senseonics Holdings, Inc. announced that it has received CE Mark approval for the next-generation Eversense® E3 CGM System, the longest-lasting system available, with exceptional accuracy.

June 16, 2022
·
6 min read
Pharm Country

Esteve Launches INBRIJA® in Germany

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Esteve Pharmaceuticals GmbH has launched INBRIJA ® 33 mg (levodopa inhalation powder, hard capsules) in Germany.

June 16, 2022
·
5 min read
Genetown

Checkpoint Therapeutics Announces Positive Interim Results from Registration-Enabling Trial of Cosibelimab in Locally Advanced Cutaneous Squamous Cell Carcinoma

Objective response rate of 54.8% in patients with locally advanced cSCC, a potential 2nd indication for cosibelimab.

June 16, 2022
·
8 min read
INmune Bio, Inc. Presents Data on Combination Therapy with INB03™ on Overcoming Resistance to HER2 Targeted Therapies in Breast Cancer

In pre-clinical models of trastuzumab resistant MUC4 HER2+ breast cancer, treatment with INB03™ decreases MUC4 expression, reverses resistance to trastuzumab based therapies, and promotes an immunologically active TME.

June 16, 2022
·
6 min read
Deals

Panbela Therapeutics, Inc. Closes Acquisition of Cancer Prevention Pharmaceuticals, Inc.

Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with cancer, today announced the closing of its acquisition of Cancer Prevention Pharmaceuticals, Inc.

June 16, 2022
·
6 min read
Business

GlycoEra AG Announces Appointment of Tanmoy Ganguly, Ph.D., as Chief Scientific Officer

R&D leader will execute company’s strategic focus on leveraging CustomGlycan to develop novel therapeutics that degrade circulating and membrane proteins that cause disease.

June 16, 2022
·
3 min read
Business

Koneksa and Northwestern University Awarded a Grant from The Michael J. Fox Foundation to Investigate Speech Symptoms in Parkinson’s Disease

Koneksa , a healthcare technology company pioneering digital biomarkers, announced today that it has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) in collaboration with Northwestern University.

June 16, 2022
·
2 min read
Business

Tachyum Signs Memorandum of Understanding with KInIT

Tachyum ™ today announced it has entered into an agreement with Kempelen Institute of Intelligent Technologies (KInIT) in Slovakia to collaborate on scientific research and innovations in artificial intelligence (AI); initiate scientific and commercial cooperation on matters of common interest.

June 16, 2022
·
4 min read
Lone Star Bio

Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic

Innovation Passport Awarded to Molgramostim for the Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP), a Rare Lung Disease.

June 16, 2022
·
5 min read
Business

PerkinElmer and Novartis Collaborate to Address the Unmet Need of Sickle Cell Disease in Sub-Saharan Africa

PerkinElmer’s contributions to the Novartis Africa Sickle Cell Disease program will accelerate access to sickle cell disease screening and treatment across the continent.

June 16, 2022
·
4 min read